Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs

With programs from Eisai and Hansoh Pharmaceutical in hand, Tortugas Neuroscience has emerged with hopes of delivering daily oral treatments to patients with central nervous system conditions.